Research Library

The relationship between President Joe Biden and Mexico's President Andrés Manuel López Obrador has not been easy, and emerging trade issues are about to make it worse.

With the rise of online trading and over 10 million new retail brokerage accounts added in 2020, are new traders ready for the associated capital gains tax rules? Public finance fellow Joyce Beebe explains some key tax considerations on the Baker Institute Blog: bit.ly/3vDeXfD

This brief explores pressing issues the Biden administration should address in developing a strategy for the Middle East. It provides analysis and policy recommendations related to the GCC states, U.S.-Iran relations, Islamist groups, and refugees and migration. Further CME publications will address issues such as the prospects for Israeli-Palestinian peace and the crisis in Lebanon.

The current situation at the U.S.-Mexico border is neither a unique crisis nor the result (yet) of President Biden’s policy changes.

The authors assess the impact of Mexico's 2014 energy reform on consumer welfare.

Fellow Katharine Neill Harris testified before the U.S. House Judiciary Committee on the failed war on drugs and solutions based on racial justice and harm reduction.

"Although there is evidence that living in a low-income neighborhood can have negative health impacts, resident and neighborhood attributes [such as the ability to bounce back from adversity] can be mitigating factors,” write the authors.

Jim Blackburn, co-director of Rice’s SSPEED Center and a Baker Institute Rice faculty scholar, examines what the city of Houston has done to prepare for flooding and other extreme weather events brought about by climate change since Hurricane Harvey struck Houston more than three years ago.

What are Mexico's prospects for immigration, trade and more, after President Andrés Manuel López Obrador's virtual meeting with President Biden? "Mexico will have to do some heavy lifting," predicts Tony Payan, director of the Center for the United States and Mexico.

Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.